Home›Research›Compare›CJC-1295 (without DAC) vs MGF
Peptide ComparisonCJC-1295 (without DAC) vs MGF
Both are GH / IGF Axis peptides.
CJC-1295 (without DAC)
CJC-1295
Half-life: ~30 minutes
446 providers listed
MGF
Mechano Growth Factor
Half-life: Minutes (rapidly degraded; PEG-MGF for extended action)
15 providers listed
CJC-1295 (without DAC) is carried by more providers on PeptideBase (446 vs 15); otherwise the two are closely matched on the measures we track.
CJC-1295 (without DAC)
Evidence
Half-life
~30 minutes
MGF
Evidence
Half-life
Minutes (rapidly degraded; PEG-MGF for extended action)
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | MGF |
| More provider options (446 vs 15) | CJC-1295 (without DAC) |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
CJC-1295 (without DAC)
MGF
CJC-1295 (without DAC)
About CJC-1295 (without DAC)
CJC-1295 without DAC (Mod GRF 1-29) is a short-acting GHRH analog that binds and activates pituitary GHRH receptors to stimulate brief, pulsatile growth hormone release. Lacking the Drug Affinity Complex, it is not albumin-bound and clears within roughly half an hour, producing discrete GH pulses rather than the sustained elevation of the DAC form.
About MGF
Splice variant of IGF-1; acts locally at site of muscle damage to activate satellite cells (muscle stem cells) for repair and hypertrophy
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
CJC-1295 (without DAC)
Class-based (investigational)
Research protocols routinely measure IGF-1 to track GH axis activity before and during use. Fasting glucose and insulin are monitored because GH elevation can reduce insulin sensitivity over time.
global — WADA
This compound falls under WADA Prohibited List category S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), prohibited at all times for competing athletes.
sourceMGF
Under clinical review
Being verified by our medical team before we display contraindications for this peptide.
CJC-1295 (without DAC)
Ipamorelin
Research suggests Ipamorelin and CJC-1295 may produce enhanced growth hormone release effects when combined. CJC-1295 provides sustained GHRH receptor stimulation while Ipamorelin provides pulsatile ghrelin receptor stimulation — complementary pathways studied in GH secretion research.
GLP-1 agonists
Research notes metabolic pathway overlap between growth hormone-releasing peptides and GLP-1 agonists. Both compound classes influence metabolic signaling; limited research has studied their combined effects. Consult your prescriber before combining.
CJC-1295 (without DAC)
MGF
Not enough vendor pricing yet.
Where to source these peptides
CJC-1295 (without DAC)
446 listed
Browse directory →
Providers offeringMGF
15 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More GH / IGF Axis Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated July 20, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). CJC-1295 (without DAC) vs MGF — Per-mg Price Comparison. Retrieved July 22, 2026, from https://peptidebase.io/peptides/compare/cjc-1295/mgf